Publications (59)

2023

  1. Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry

    Journal of the European Academy of Dermatology and Venereology, Vol. 37, Núm. 1, pp. 57-64

  2. Expression of angiogenic and lymphangiogenic genes in primary cutaneous melanoma: relationship with angiolymphatic invasion and disease-free survival

    Melanoma research, Vol. 33, Núm. 5, pp. 375-387

  3. Ocrelizumab, an alternative to rituximab in refractory pemphigus vulgaris management

    Journal of the European Academy of Dermatology and Venereology

  4. Primary Cutaneous Lymphoma Registry of the Spanish Academy of Dermatology and Venereology (AEDV): Data for the First 5 Years

    Actas Dermo-Sifiliograficas, Vol. 114, Núm. 4, pp. 291-298

  5. Sonidegib as a Locally Advanced Basal Cell Carcinoma Therapy in Real-life Clinical Setting: A National Multicentre Study

    Actas Dermo-Sifiliograficas, Vol. 114, Núm. 7, pp. T565-T571

2022

  1. Activity and safety of topical pimecrolimus in patients with early stage mycosis fungoides (PimTo-MF): a single-arm, multicentre, phase 2 trial

    The Lancet Haematology, Vol. 9, Núm. 6, pp. e425-e433

2021

  1. Gene Expression Studies in Formalin-Fixed Paraffin-Embedded Samples of Cutaneous Cancer: The Need for Reference Genes

    Current issues in molecular biology, Vol. 43, Núm. 3, pp. 2167-2176

  2. Patients with primary cutaneous lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry

    Journal of the European Academy of Dermatology and Venereology

  3. Primary cutaneous lymphomas in children: A prospective study from the Spanish Academy of Dermatology and Venereology (AEDV) Primary Cutaneous Lymphoma Registry

    Pediatric Dermatology, Vol. 38, Núm. 6, pp. 1506-1509

2020

  1. Cost of early-stage mycosis fungoides treatments in Spain

    ClinicoEconomics and Outcomes Research, Vol. 12, pp. 91-105

  2. Prognostic factors in patients with primary cutaneous anaplastic large cell lymphoma: a multicentric, retrospective analysis of the Spanish Group of Cutaneous Lymphoma

    Journal of the European Academy of Dermatology and Venereology, Vol. 34, Núm. 4, pp. 762-768

  3. Systemic rituximab for the treatment of the indolent forms of primary cutaneous B-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry

    Journal of the American Academy of Dermatology, Vol. 83, Núm. 5, pp. 1535-1538

2019

  1. MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort

    The Lancet Child and Adolescent Health, Vol. 3, Núm. 5, pp. 332-342

  2. Referral of Patients to Dermatology and Teledermatology Consultations in Spain. DIADERM Study

    Actas Dermo-Sifiliograficas, Vol. 110, Núm. 2, pp. 146-152

2018

  1. Association of APOA5 and APOC3 Genetic Polymorphisms with Severity of Hypertriglyceridemia in Patients with Cutaneous T-Cell Lymphoma Treated with Bexarotene

    JAMA Dermatology, Vol. 154, Núm. 12, pp. 1424-1431

  2. First-line treatment in lymphomatoid papulosis: a retrospective multicentre study

    Clinical and Experimental Dermatology, Vol. 43, Núm. 2, pp. 137-143

  3. The First Year of the AEVD Primary Cutaneous Lymphoma Registry

    Actas Dermo-Sifiliograficas, Vol. 109, Núm. 7, pp. 610-616

2016

  1. Association of Melanocortin-1 Receptor Variants with Pigmentary Traits in Humans: A Pooled Analysis from the M-Skip Project

    Journal of Investigative Dermatology, Vol. 136, Núm. 9, pp. 1914-1917

2015

  1. Does the new staging system proposed for mycosis fungoides and sézary syndrome provide reliable agreement for T1 and T2 disease?

    Dermatology, Vol. 230, Núm. 1, pp. 40-45

  2. MC1R gene variants and non-melanoma skin cancer: A pooled-analysis from the M-SKIP project

    British Journal of Cancer, Vol. 113, Núm. 2, pp. 354-363